948
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Loke zupa decoction attenuates bronchial EMT-mediated airway remodelling in chronic asthma through the PI3K-Akt/HIF-1α signaling pathway

, ORCID Icon, , &
Pages 1332-1342 | Received 13 Jan 2023, Accepted 31 Jul 2023, Published online: 01 Sep 2023

References

  • Abduwaki M, Abdukadir A, Eziz A, Nasir G, Hojahmat H, Nurahmat M. 2017. Uygur medicine to treat asthma preparations LuoouKe zupa research overview. XinJiang Med J. 47:123–128. Chinese.
  • Aihaiti K, Li J, Yaermaimaiti S, Liu L, Xin X, Aisa HA. 2022. Non-volatile compounds of Hyssopus cuspidatus Boriss. and their antioxidant and antimicrobial activities. Food Chem. 374:131638. doi: 10.1016/j.foodchem.2021.131638.
  • Bullone M, Lavoie JP. 2020. The equine asthma model of airway remodelling: from a veterinary to a human perspective. Cell Tissue Res. 380(2):223–236. doi: 10.1007/s00441-019-03117-4.
  • Bergeron C, Pagé N, Joubert P, Barbeau B, Hamid Q, Chakir J. 2003. Regulation of procollagen I (alpha1) by interleukin-4 in human bronchial fibroblasts: a possible role in airway remodelling in asthma. Clin Exp Allergy. 33(10):1389–1397. doi: 10.1046/j.1365-2222.2003.01785.x.
  • Chung KF. 2017. Clinical management of severe therapy-resistant asthma. Expert Rev Respir Med. 11(5):395–402. doi: 10.1080/17476348.2017.1317597.
  • Caramori G, Nucera F, Mumby S, Bello FL, Adcock IM. 2022. Corticosteroid resistance in asthma: cellular and molecular mechanisms. Mol Aspects Med. 85:100969. doi: 10.1016/j.mam.2021.100969.
  • Derendorf H, Nave R, Drollmann A, Cerasoli F, Wurst W. 2006. Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma. Eur Respir J. 28(5):1042–1050. doi: 10.1183/09031936.00074905.
  • Dahlin A, Qiu W, Litonjua AA, John JL, Mayumi T, Michiaki K, Irvin CG, Peters SP, Wu AC, Weiss ST, et al. 2018. The phosphatidylinositide3-kinase (PI3K) signaling pathway is a determinant of zileuton response in adults with asthma. Pharmacogenomics J. 18(5):665–677. doi: 10.1038/s41397-017-0006-0.
  • Dong LY, Wang Y, Zheng TT, Pu YN, Ma YB, Qi X, Zhang WZ, Xue F, Shan ZR, Liu JM, et al. 2021. Hypoxic hUCMSC-derived extracellular vesicles attenuate allergic airway inflammation and airway remodelling in chronic asthma mice. Stem Cell Res Ther. 12(1):4. doi: 10.1186/s13287-020-02072-0.
  • Fehrenbach H, Wagner C, Wegmann M. 2017. Airway remodelling in asthma: what really matters. Cell Tissue Res. 367(3):551–569. doi: 10.1007/s00441-016-2566-8.
  • Gosens R, Grainge C. 2015. Bronchoconstriction and airway biology: potential impact and therapeutic opportunities. Chest. 147(3):798–803. doi: 10.1378/chest.14-1142.
  • Grainge C, Lau LK, Ward JA, Dulay V, Lahiff G, Wilson S, Holgate S, Davies DE, Howarth PH. 2011. Effect of bronchocon-striction on airway remodelling in asthma. N Engl J Med. 364(21):2006–2015. doi: 10.1056/NEJMoa1014350.
  • Ganesan S, Sajjan US. 2013. Repair and remodelling of airway epithelium after injury in chronic obstructive pulmonary disease. Curr Respir Care Rep. 2:145–154. doi: 10.1007/s13665-013-0052-2.
  • Ingram JL, Kraft M. 2012. IL-13 in asthma and allergic disease: asthma phenotypes and targeted therapies. J Allergy Clin Immunol. 130(4):829–842. doi: 10.1016/j.jaci.2012.06.034.
  • Kalluri RH, Weinberg RA. 2009. The basics of epithelial-mesenchymal transition. J Clin Invest. 119(6):1420–1428. doi: 10.1172/JCI39104.
  • Lee CG, Homer RJ, Zhu Z, Lanone S, Wang X, Koteliansky V, Shipley JM, Gotwals P, Noble P, Chen Q, et al. 2001. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta (1). J Exp Med. 194(6):809–821. doi: 10.1084/jem.194.6.809.
  • Li W, Li L, Wang XM, Diao JJ, Wang XL. 2021. Determination of total polyphenols and total flavonoids in compound Lok and study on antioxidant activity. J Xinjiang Med Univ. 44:842–845. Chinese.
  • Mohammadtursun N, Li QP, Abuduwaki M, Jiang S, Zhang H, Sun J, Dong JC. 2020. Loki zupa alleviates inflammatory and fibrotic responses in cigarette smoke induced rat model of chronic obstructive pulmonary disease. Chin Med. 15:92. doi: 10.1186/s13020-020-00373-3.
  • Pei DQ, Shu XD, Diagne AG, Thiery JP. 2019. Mesenchymal-epithelial transition in development and reprogramming. Nat Cell Biol. 21(1):44–53. doi: 10.1038/s41556-018-0195-z.
  • Riemma MA, Cerqua I, Romano B, Irollo E, Bertolino A, Camerlingo R, Granato E, Rea G, Scala S, Terlizzi M, et al. 2022. Sphingosine-1-phosphate/TGF-β axis drives epithelial mesenchymal transition in asthma-like disease. Br J Pharmacol. 179(8):1753–1768. doi: 10.1111/bph.15754.
  • Samitas K, Carter A, Kariyawasam HH, Xanthou G. 2018. Upper and lower airway remodelling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: the one airway concept revisited. Allergy. 73(5):993–1002. doi: 10.1111/all.13373.
  • Sheih A, Parks WC, Ziegler SF. 2017. GM-CSF produced by the airway epithelium is required for sensitization to cockroach allergen. Mucosal Immunol. 10(3):705–715. doi: 10.1038/mi.2016.90.
  • Wang HS, Kim JY, Park H, Jeong J, Hyun H, Yoon TJ, Park H-Y, Choi H-D, Kim HH. 2014. Cleavage of the terminal N-acetylglucosamine of egg-white ovalbumin N-glycans significantly reduces IgE production and Th2 cytokine secretion. Biochem Biophys Res Commun. 450(4):1247–1254.,. doi: 10.1016/j.bbrc.2014.06.101.
  • Wang XZ, Xu CY, Ji JY, Cai YQ, Shu YY, Chao YQ, Wu XL, Zou CH, Wu XM, Tang LF. 2020. IL-4/IL-13 upregulates Sonic hedgehog expression to induce allergic airway epithelial remodelling. Am J Physiol Lung Cell Mol Physiol. 318(5):L888–L899. doi: 10.1152/ajplung.00186.2019.
  • Wei Y, Abduwaki M, Li MH, Luo QL, Sun J, Lv YB, Nurahmat M, Dong JC. 2016. Lok (Luooukezupa) decoction reduced airway inflammation in an OVA-induced asthma mouse model. Chin Med. 11:22. doi: 10.1186/s13020-016-0094-9.
  • Wei L, Gou XL, Su B, Han HQ, Guo TT, Liu L, Wang L, Zhang L, Chen WB, Lina W, et al. 2022. Mahuang decoction attenuates airway inflammation and remodelling in asthma via suppression of the SP1/FGFR3/PI3K/AKT axis. Drug Des Devel Ther. 16:2833–2850. doi: 10.2147/DDDT.S351264.
  • Wuniqiemu T, Qin J, Teng F, Nabijan M, Cui J, Yi L, Tang W, Zhu XY, Abduwaki M, Nurahmat M, et al. 2021. Quantitative proteomic profiling of targeted proteins associated with Lok decoction treatment in ova-induced asthmatic mice. J Ethnopharmacol. 266:113343. doi: 10.1016/j.jep.2020.113343.
  • Xie C, Gul A, Yu H, Huang X, Deng LL, Pan Y, Ni SS, Nurahmat M, Abduwaki M, Luo QL, et al. 2022. Integrated systems pharmacology and transcriptomics to dissect the mechanisms of Loki Zupa decoction in the treatment of murine allergic asthma. J Ethnopharmacol. 294:115351. doi: 10.1016/j.jep.2022.115351.
  • Ye B, Jiang LL, Xu HT, Zhou DW, Li ZS. 2012. Expression of PI3K/Akt pathway in gastric cancer and its blockade suppresses tumor growth and metastasis. Int J Immunopathol Pharmacol. 25(3):627–636. doi: 10.1177/039463201202500309.
  • Ye ZX, Jiang YF, Wu JL. 2022. DNMT3B attenuated the inhibition of TET3 on epithelial-mesenchymal transition in TGF-β1-induced ovarian cancer by methylating the TET3 promoter. Reprod Biol. 22(4):100701. doi: 10.1016/j.repbio.2022.100701.
  • Yuan FJ, Liu R, Hu M, Rong XJ, Bai LP, Xu L, Mao Y, Hasimu H, Sun YH, He JH. 2019. JAX2, an ethanol extract of Hyssopus cuspidatus Boriss., can prevent bronchial asthma by inhibiting MAPK/NF-kappaB inflammatory signaling. Phytomedicine. 57:305–314. doi: 10.1016/j.phymed.2018.12.043.
  • Yao L, Wang S, Wei P, Bao K, Yuan W, Wang X, Zheng J, Hong M. 2019. Huangqi-Fangfeng protects against allergic airway remodelling through inhibiting epithelial-mesenchymal transition process in mice via regulating epithelial derived TGF-b1. Phytomedicine. 64:153076. doi: 10.1016/j.phymed.2019.153076.
  • Zhao X, Yu FQ, Huang XJ, Xu BY, Li YL, Zhao XY, et al. 2018. Azithromycin influences airway remodelling in asthma via the PI3K/Akt/MTOR/HIF-1α/VEGF pathway. J Biol Regul Homeost Agents. 32:1079–1088.
  • Zhou B, Zhou X, Zhan C, Jin M, Yan S. 2023. FAM83A promotes the progression and metastasis of human pancreatic neuroendocrine tumors by inducing the epithelial-mesenchymal transition via the PI3K/AKT and ERK pathways. J Endocrinol Invest. 46(6):1115–1130. doi: 10.1007/s40618-022-01959-4.